The Evolution of Breast Implant Infections: Serratia marcescens Is an Emerging Pathogen in Implant-Based Breast Reconstruction

scientific article published on 21 February 2019

The Evolution of Breast Implant Infections: Serratia marcescens Is an Emerging Pathogen in Implant-Based Breast Reconstruction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/2292550319826098
P932PMC publication ID6505359
P698PubMed publication ID31106178

P2093author name stringKant Y Lin
Jane L Gui
P2860cites workUpdate on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.Q46005562
Population-based laboratory surveillance for Serratia species isolates in a large Canadian health regionQ46932158
Bacterial endocarditis due to Chromobacterium prodigiosum; report of a caseQ50318966
Infectious complications following breast reconstruction with expanders and implants.Q51840187
NIDDM and prevalence of nasal Staphylococcus aureus colonization. San Luis Valley Diabetes StudyQ69579953
Augmentation mammaplasty. Survey of complications in 10,941 patients by 265 surgeonsQ71506425
Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the handsQ79323850
Frequent human isolation of Serratia marcescens. Bacteriological and pathogenicity studies of twelve strains of S. marcescens recovered from nine patients during a six-month periodQ79393369
Serratia infections: from military experiments to current practiceQ30424691
Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims DataQ30964042
Prevalence and characteristics of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus nasal colonization among a community-based diabetes population in Foshan, China.Q33633695
The story of serratia marcescens: pathologic risk factors in breast implant surgeryQ33962980
Pink Breast Milk: Serratia marcescens ColonizationQ34550402
Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated geneQ37174163
Serratia marcescens surgical wound infection following breast reconstructionQ37413437
Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumoniaQ37769547
Breast Implant Infections: Is Cefazolin Enough?Q37784667
Breast implant infections after surgical reconstruction in patients with breast cancer: assessment of risk factors and pathogens over extended post-operative observationQ38008487
Mutations in components of antiviral or microbial defense as a basis for breast cancer.Q38140679
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast CancerQ38974396
Cancer Statistics, 2017.Q39038674
The Occurrence and Bacteriological Characteristics of S. marcescens from a Case of Meningitis.Q40697968
Pathogenic carrier rate in diabetes mellitusQ41512100
Preventing surgical-site infections in nasal carriers of Staphylococcus aureusQ43201082
Factors affecting staphylococcal colonization among NIDDM outpatientsQ44675713
Prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in a diabetic outpatient population: a prospective cohort studyQ44923077
Nasal colonization with Staphylococcus aureus in patients with diabetes mellitusQ45239817
P433issue2
P921main subjectSerratia marcescensQ140004
emerging pathogenQ108429945
P304page(s)182-188
P577publication date2019-02-21
P1433published inPlastic surgery (Oakville, Ont.)Q27726318
P1476titleThe Evolution of Breast Implant Infections: Serratia marcescens Is an Emerging Pathogen in Implant-Based Breast Reconstruction
P478volume27

Search more.